84
78
Growth Score 84 in past quarter
-3 pts
Heat Score 78 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
331866
Polygen Pharmaceuticals is a generic pharmaceutical company.
Prasad Venegalia: Executive Vice President, Executive Officer
About the Company
Polygen Pharmaceuticals is a generic pharmaceutical company that provides services in the licencing, development, marketing, sales, and distribution of generic pharmaceutical products for the prescription medicine market. Polygen Pharmaceuticals has a solid product pipeline and plans to deliver new generic medications in the coming years as its
pipeline matures through the regulatory clearance cycle.
